Published in Curr Hematol Rep on November 01, 2003
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit. Br J Clin Pharmacol (2013) 1.28
Science review: recombinant human erythropoietin in critical illness: a role beyond anemia? Crit Care (2004) 1.07
Functional erythropoietin autocrine loop in melanoma. Am J Pathol (2005) 1.06
Simultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesis. Clin Transl Sci (2008) 1.00
Skeletal muscle alterations and exercise performance decrease in erythropoietin-deficient mice: a comparative study. BMC Med Genomics (2012) 0.95
Erythropoietin in spinal cord injury. Eur Spine J (2008) 0.95
Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats. Mol Med (2007) 0.94
Evaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjects. PLoS One (2012) 0.85
Targeting Neovascularization in Ischemic Retinopathy: Recent Advances. Expert Rev Ophthalmol (2013) 0.84
Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact. Eur J Clin Pharmacol (2010) 0.84
The antioxidant effect of erythropoietin on thalassemic blood cells. Anemia (2010) 0.78
Erythropoietin increases bioavailability of tetrahydrobiopterin and protects cerebral microvasculature against oxidative stress induced by eNOS uncoupling. J Neurochem (2014) 0.77
Epo inhibits the fibrosis and migration of Müller glial cells induced by TGF-β and high glucose. Graefes Arch Clin Exp Ophthalmol (2016) 0.77
Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivo. Lipids Health Dis (2016) 0.76
AG490 suppresses EPO-mediated activation of JAK2-STAT but enhances blood flow recovery in rats with critical limb ischemia. J Inflamm (Lond) (2016) 0.76
Effects of Human Erythropoietin on Functional Outcome of Patients with Traumatic Cervical Cord Injury; A Pilot Randomized Clinical Trial. Bull Emerg Trauma (2015) 0.75
Erythropoietin in the critically ill - is it more than just blood? Crit Care (2004) 0.75
Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection. Front Cell Neurosci (2017) 0.75
Dose effect evaluation and therapeutic window of the neuro-EPO nasal application for the treatment of the focal ischemia model in the Mongolian gerbil. ScientificWorldJournal (2012) 0.75
Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science (2004) 4.09
Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med (2002) 3.87
Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med (2003) 2.37
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A (2003) 2.28
Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A (2002) 2.16
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2002) 2.08
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A (2003) 1.88
Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A (2002) 1.66
Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A (2004) 1.65
Ventricular non-compaction in children: clinical characteristics and course. Interact Cardiovasc Thorac Surg (2010) 1.40
Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor. Kidney Int (2013) 1.37
Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. Mol Med (2012) 1.33
Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J Neuroimmunol (2005) 1.26
Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res (2004) 1.25
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2005) 1.24
Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab (2006) 1.21
Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med (2006) 1.21
Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist (2004) 1.18
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc Natl Acad Sci U S A (2008) 1.17
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin Cancer Res (2006) 1.15
Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin. Proc Natl Acad Sci U S A (2010) 1.14
ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and β-common receptor knockout mice. Anesthesiology (2011) 1.11
Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative. J Neurosurg Spine (2006) 1.09
Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc Natl Acad Sci U S A (2005) 1.07
Science review: recombinant human erythropoietin in critical illness: a role beyond anemia? Crit Care (2004) 1.07
Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes (2011) 1.06
Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci U S A (2006) 1.05
Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proc Natl Acad Sci U S A (2012) 1.02
A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage. Mol Med (2010) 1.02
Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing. Mol Med (2009) 1.00
Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proc Natl Acad Sci U S A (2009) 1.00
The effects of hyaluronic acid, epidermal growth factor, and mitomycin in an experimental model of acute traumatic tympanic membrane perforation. Otol Neurotol (2003) 1.00
ARA 290 for treatment of small fiber neuropathy in sarcoidosis. Expert Opin Investig Drugs (2014) 0.97
Hyperoxic exposure leads to cell death in the developing brain. Brain Dev (2008) 0.97
Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res (2005) 0.96
Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. J Pharmacol Exp Ther (2005) 0.96
Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate (2004) 0.96
Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure? Heart Fail Rev (2008) 0.95
Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice. Exp Neurol (2007) 0.95
Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol (2011) 0.95
Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr Res (2005) 0.94
A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock. Mol Med (2011) 0.94
Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats. Mol Med (2007) 0.94
Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate (2003) 0.94
Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J Investig Med (2011) 0.92
Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neonatology (2007) 0.92
Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia. Proc Natl Acad Sci U S A (2006) 0.92
Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury. Mol Med (2012) 0.91
Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia. Exp Neurol (2011) 0.90
Evaluation of the effect of acetyl L-carnitine on experimental cisplatin nephrotoxicity. Chemotherapy (2009) 0.90
Erythropoietin: not just about erythropoiesis. Lancet (2010) 0.90
Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation. Biol Neonate (2003) 0.89
Carbamylated erythropoietin reduces radiosurgically-induced brain injury. Mol Med (2006) 0.89
Effects of activated protein C on neonatal hypoxic ischemic brain injury. Brain Res (2008) 0.88
Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns. Proc Natl Acad Sci U S A (2013) 0.88
The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats. Perit Dial Int (2007) 0.88
Ginseng ameliorates chronic histopathologic changes in a murine model of asthma. Allergy Asthma Proc (2008) 0.87
Activated protein C reduces endotoxin-induced white matter injury in the developing rat brain. Brain Res (2007) 0.87
Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Ther (2007) 0.87
Selective inhibition of nitric oxide in hypoxic-ischemic brain model in newborn rats: is it an explanation for the protective role of erythropoietin? Biol Neonate (2003) 0.86
Neuroprotective properties of epoetin alfa. Nephrol Dial Transplant (2002) 0.86
Effects of Ginkgo biloba on airway histology in a mouse model of chronic asthma. Allergy Asthma Proc (2008) 0.85
Otoprotective effect of recombinant erythropoietin in a model of newborn hypoxic-ischemic encephalopathy. Int J Pediatr Otorhinolaryngol (2013) 0.85
Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial. J ECT (2010) 0.85
Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury. Biol Neonate (2005) 0.85
Effect of retinoic acid on oxygen-induced lung injury in the newborn rat. Pediatr Pulmonol (2005) 0.84
Suppression of coronary atherosclerosis by helix B surface Peptide, a nonerythropoietic, tissue-protective compound derived from erythropoietin. Mol Med (2013) 0.83
Recombinant human erythropoietin for neuroprotection: what is the evidence? Clin Breast Cancer (2002) 0.83
Unilateral ureteroperitoneostomy in the management of hypoproteinemia in nephrotic rats with normal renal function. Tohoku J Exp Med (2003) 0.82
Effect of Hedera helix on lung histopathology in chronic asthma. Iran J Allergy Asthma Immunol (2012) 0.82
Comparison of efficacy of ivermectin and doramectin against mange mite (Sarcoptes scabiei) in naturally infested rabbits in Turkey. Vet Ital (2010) 0.82
Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn. Pediatr Pulmonol (2014) 0.82
Erythropoietin attenuates neuronal injury and potentiates the expression of pCREB in anterior horn after transient spinal cord ischemia in rats. Surg Neurol (2007) 0.82
Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy. J Pharmacol Exp Ther (2013) 0.82
Aortic coarctation with Down syndrome. Med Sci Monit (2011) 0.81
Maternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brain. J Matern Fetal Neonatal Med (2011) 0.81
Effects of curcumin on lung histopathology and fungal burden in a mouse model of chronic asthma and oropharyngeal candidiasis. Arch Med Res (2011) 0.81
ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response. Mol Pain (2014) 0.81
Anthropometric variables accurately predict dual energy x-ray absorptiometric-derived body composition and can be used to screen for diabetes. PLoS One (2011) 0.81
Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats. Brain Res (2006) 0.81
Effect of erythropoietin on oxygen-induced brain injury in the newborn rat. Neurosci Lett (2008) 0.80
Effects of selenium supplementation on antioxidant defense and glucose homeostasis in experimental diabetes mellitus. Biol Trace Elem Res (2007) 0.80
In vivo proton magnetic resonance spectroscopic examination of benzodiazepine action in humans. Psychiatry Res (2010) 0.80
Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-β, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis. Ren Fail (2011) 0.80
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma. Exp Lung Res (2008) 0.80
Antinociceptive and neurotoxicologic screening of chronic intrathecal administration of ketorolac tromethamine in the rat. Anesth Analg (2004) 0.80
Erythropoietin prevents lymphoid apoptosis but has no effect on survival in experimental sepsis. Pediatr Res (2013) 0.79
Influence of uracil on bacterial translocation in an intestinal obstruction model in rats. Int J Surg (2012) 0.79
Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131). PLoS One (2013) 0.79
Effects of N-acetylcysteine on radiocontrast nephropathy in rats. Scand J Urol Nephrol (2006) 0.79